264 related articles for article (PubMed ID: 8855783)
1. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study.
Grey A; Mitnick MA; Shapses S; Ellison A; Gundberg C; Insogna K
J Clin Endocrinol Metab; 1996 Oct; 81(10):3450-4. PubMed ID: 8855783
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle.
Gorai I; Taguchi Y; Chaki O; Kikuchi R; Nakayama M; Yang BC; Yokota S; Minaguchi H
J Clin Endocrinol Metab; 1998 Feb; 83(2):326-32. PubMed ID: 9467535
[TBL] [Abstract][Full Text] [Related]
4. Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women.
Insogna K; Mitnick M; Pascarella J; Nakchbandi I; Grey A; Masiukiewicz U
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N108-16. PubMed ID: 12412787
[TBL] [Abstract][Full Text] [Related]
5. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
[TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-6 in renal osteodystrophy: relationship with serum PTH and bone remodeling markers.
Montalbán C; García-Unzueta MT; De Francisco AL; Amado JA
Horm Metab Res; 1999 Jan; 31(1):14-7. PubMed ID: 10077343
[TBL] [Abstract][Full Text] [Related]
7. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women.
McKane WR; Khosla S; Peterson JM; Egan K; Riggs BL
J Bone Miner Res; 1994 Aug; 9(8):1313-8. PubMed ID: 7976512
[TBL] [Abstract][Full Text] [Related]
9. The role of cytokines in the changes in bone turnover following bone marrow transplantation.
Lee WY; Kang MI; Oh ES; Oh KW; Han JH; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
Osteoporos Int; 2002 Jan; 13(1):62-8. PubMed ID: 11878457
[TBL] [Abstract][Full Text] [Related]
10. Bone turnover in prolonged critical illness: effect of vitamin D.
Van den Berghe G; Van Roosbroeck D; Vanhove P; Wouters PJ; De Pourcq L; Bouillon R
J Clin Endocrinol Metab; 2003 Oct; 88(10):4623-32. PubMed ID: 14557432
[TBL] [Abstract][Full Text] [Related]
11. The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism.
Nakchbandi IA; Lang R; Kinder B; Insogna KL
J Clin Endocrinol Metab; 2008 Mar; 93(3):967-73. PubMed ID: 18073309
[TBL] [Abstract][Full Text] [Related]
12. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.
Valdemarsson S; Lindergård B; Tibblin S; Bergenfelz A
J Intern Med; 1998 Feb; 243(2):115-22. PubMed ID: 9566639
[TBL] [Abstract][Full Text] [Related]
13. The effect of simvastatin on serum cytokine levels and bone metabolism in postmenopausal subjects: negative correlation between TNF-alpha and anabolic bone parameters.
Tikiz C; Unlü Z; Tikiz H; Ay K; Angin A; Onur E; Var A; Tüzün C
J Bone Miner Metab; 2004; 22(4):365-71. PubMed ID: 15221496
[TBL] [Abstract][Full Text] [Related]
14. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.
Seibel MJ; Woitge HW; Pecherstorfer M; Karmatschek M; Horn E; Ludwig H; Armbruster FP; Ziegler R
J Clin Endocrinol Metab; 1996 Sep; 81(9):3289-94. PubMed ID: 8784085
[TBL] [Abstract][Full Text] [Related]
15. Short-term effect of parathyroidectomy on biochemical markers in primary and secondary hyperparathyroidism.
Hoshino H; Kushida K; Takahashi M; Denda M; Yamazaki K; Yamanashi A; Inoue T
Miner Electrolyte Metab; 1997; 23(2):93-9. PubMed ID: 9252975
[TBL] [Abstract][Full Text] [Related]
16. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
18. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
Akalin A; Colak O; Alatas O; Efe B
Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
[TBL] [Abstract][Full Text] [Related]
19. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women.
Charatcharoenwitthaya N; Khosla S; Atkinson EJ; McCready LK; Riggs BL
J Bone Miner Res; 2007 May; 22(5):724-9. PubMed ID: 17295604
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma.
Abildgaard N; Glerup H; Rungby J; Bendix-Hansen K; Kassem M; Brixen K; Heickendorff L; Nielsen JL; Eriksen EF
Eur J Haematol; 2000 Feb; 64(2):121-9. PubMed ID: 10997332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
